Colleen H. Dansereau MSN, RN, CPN

Ms. Dansereau is an experienced pediatric hematology-oncology registered nurse with an extensive background and experience in both clinical research and clinical operations, specifically in the area of gene and cellular therapies. She has developed an extensive research infrastructure that supports over 14+ gene therapy clinical trials using in vivo, ex vivo and gene editing strategies at Boston Children’s Hospital. She is responsible for providing leadership for the development of operational strategies, planning and readiness for introducing newly FDA approved commercial gene therapies into the clinical setting at Boston Children’s Hospital.